Z-Cube sets aside €60m for pharmaceutical start-ups
The Italian company Zambon has set up a project called Z-Cube, which will award €60m of financing to create 24 new pharmaceutical companies with links to universities and research centres. Around €7m of this amount will be used to fund 60 business plans. A team of experts from Zambon will select the most interesting projects, in collaboration with Professor Renato Dullbeco, who won the Nobel Prize for Medicine. Z-Cube is currently working with the University of Milan, the Instituto Mario Negri and the Istituto Superiore di Sanità in Italy; the Max Planck Institute in Germany; the Sitra centre in Finland; the University of Leuven and the Rega Institute in Belgium; Imperial College in the UK; and AUTM in the US. Zambon recently established a new pharma-chemical research and development centre in Barcelona which could potentially allocate part of its office space to one of the Z-Cube projects.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds
Back to Top








